|
|
||||||||
Articles |
a Department of Anatomy and Reproductive Biology, University of Hawaii Medical School, Honolulu, Hawaii 96822
b Department of Biological Sciences, Asahikawa Medical College, Asahikawa, Japan 078-8510
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Spermatozoa were collected from caudae epididymides of BALB/cAnNCr mice and hybrid mice B6D2F1 (C57BL/6 x DBA/2J). B6D2F1 females were used as oocyte donors. All mice were purchased through the National Cancer Institute and maintained in a temperature- and light-controlled room (14L:10D) for at least 2 wk before use. When used in experiments B6D2F1 mice were 612 wk old, and BALB/c mice were 69 mo old. All animals were maintained in accordance with the guidelines of the Laboratory Animal Service at the University of Hawaii and those prepared by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Resources National Research Council (DHEW publication no. [NIH] 8023, revised in 1985). The protocol of our animal handling and treatment was reviewed and approved by the Animal Care and Use Committee at the University of Hawaii.
Reagents
Polyvinyl alcohol (PVA, cold water soluble, molecular weight about 10 000) and polyvinyl pyrrolidone (PVP, molecular weight about 360 000) were purchased from Sigma Chemical Co. (St. Louis, MO). Bovine testicular hyaluronidase (200 USP U/mg) was obtained from ICN Biochemicals (Costa Mesa, CA). BSA (fraction V) was purchased from Calbiochem (La Jolla, CA) and mineral oil from Squibb and Sons (Princeton, NJ). All other reagents were obtained from Sigma unless otherwise stated.
Media
CZB medium [9] supplemented with 5.56 mM D-glucose was used for the culture of mouse oocytes after microsurgery. The medium for collection of oocytes from oviducts and subsequent oocyte treatments, including micromanipulation, was a modified CZB (Hepes-CZB [10]) containing 20 mM Hepes-HCl, a reduced amount of NaHCO3 (5 mM), and 0.1 mg/ml PVA instead of BSA. CZB was used under 5% CO2 in air, and Hepes-CZB was used under air.
Preparation of Oocytes
B6D2F1 females were each injected with 5 IU eCG followed by 5 IU hCG 48 h later. Mature oocytes were collected from oviducts about 15 h after the hCG injection. They were freed from the cumulus cells by 5-min treatment with 0.1% bovine testicular hyaluronidase in Hepes-CZB. The oocytes were rinsed, and before micromanipulation they were kept in CZB medium for up to 4 h at 37°C in 5% CO2 in air.
Classification of Head Morphology in BALB/c Spermatozoa
Sperm head morphology was classified according to Burruel et al. [8] as normal, quasi-normal, and grossly abnormal. Quasi-normal heads included those missing the rostral part of the acrosome and/or the posterolateral region of the postacrosomal region. Grossly abnormal heads included collapsed and triangular heads with highly deformed acrosomal caps and nuclei (Fig. 1).
|
Enucleation of Oocytes
The oocytes were transferred into a droplet of Hepes-CZB containing 5 µg/ml cytochalasin B, which had previously been placed in the operation chamber on the microscope stage and kept there for 510 min. Enucleation of the oocytes was performed by aspirating the metaphase II chromosome-spindle complex up into a pipette (810 µm in the inner diameter) with a minimal volume of oocyte cytoplasm [11]. Enucleated oocytes were then transferred into cytochalasin B-free CZB and kept there for up to 3 h at 37°C before sperm injection.
Intracytoplasmic Sperm Injection (ICSI)
ICSI was carried out according to Kimura and Yanagimachi [10], but with some modifications. A drop (50 µl) of sperm suspension was mixed thoroughly with 100 µl of Hepes-CZB medium containing 12% (w:v) PVP (PVP-Hepes). Part of this mixture was transferred to the micromanipulation chamber on the microscope stage. To examine whether the prior separation of the sperm head from the tail and the enucleation of mature oocytes affected the sperm chromosome complement, spermatozoa were injected in three different ways. In the first (I), a single motile spermatozoon with normal head was selected and drawn into an injection pipette of inner diameter of 78 µm at the tip. Immediately before injection, a few piezo-pulses were applied to the midpiece region of the spermatozoon to immobilize it; then its whole body was injected into an intact oocyte. In the second procedure (II), a motile spermatozoon with normal head was selected, its head was separated from tail by applying one or a few piezo-pulses to the neck region [12], and the sperm head alone was injected into an intact oocyte. In the third (III), an isolated sperm head obtained as above was injected into an enucleated oocyte. All microsurgical operations were performed at 25°C in Hepes-CZB. Sperm-injected oocytes were cultured in 50-µl droplets of CZB medium under mineral oil at 37°C.
Chromosome Examination
Seven to eight hours after ICSI, the oocytes were transferred into an another droplet (0.2 ml) of CZB containing 0.006 µg/ml vinblastine. Vinblastine prevented mingling of sperm and egg chromosomes by disrupting ooplasmic microtubules. Between 19 and 21 h after ICSI, eggs arrested at metaphase of the first cleavage were treated with 1% (w:v) Pronase (Kaken Pharmaceuticals, Tokyo, Japan) for 5 min to remove the zona pellucida, then with a hypotonic solution (1:1 mixture of 1% sodium citrate and 30% fetal bovine serum) for 10 min at room temperature. Fixation of eggs and spreading of chromosomes were performed according to Mikamo and Kamiguchi [13]. The chromosomes on slides were stained with 2% Giemsa solution for 8 min. After conventional chromosome analysis, they were C-banded [14] to detect acentric and dicentric chromosomes [13]. With use of ICSI methods I and II, an oocyte injected with a spermatozoon was considered chromosomally normal when it contained 40 structurally normal chromosomes at the metaphase of the first mitotic division, as we could not always distinguish between chromosomes derived from the male pronucleus and those from the female pronucleus. When method III was used, all the chromosomes were of sperm origin. Thus, with use of method III the normality and abnormality of sperm chromosomes could be assessed without intervention of oocyte chromosomes.
Statistical analysis was done using the chi-square test.
| RESULTS |
|---|
|
|
|---|
|
Table 2 summarizes chromosome analyses of BALB/c spermatozoa with normal and abnormal head morphologies using method III. The incidence of a normal karyotype was significantly higher in the spermatozoa with normal and quasi-normal heads than in those with severely misshapen heads (p < 0.01). The difference between normal-headed and quasi-normal-headed spermatozoa was not significant with respect to the incidence of normal/abnormal karyotypes. Regardless of sperm head morphology, the predominant types of structural chromosome aberration were breaks and exchanges of chromosome type. There was no great difference in the distribution of aberration types among the four groups of spermatozoa. X/Y ratios were not significantly different from the expected X/Y ratio (= 1) in all the groups of spermatozoa. Finally, no significant increase in aneuploidy was evident in any of the groups. The aneuploidy that did occur in this study involved chromosomes 19 (n-1) or 21 (n+1).
|
| DISCUSSION |
|---|
|
|
|---|
We found that about 35% of BALB/c spermatozoa with grossly misshapen heads (collapsed and triangular) had chromosome abnormalities, significantly higher than for those with normal or quasi-normal heads (1520%) (p < 0.010.0001) (Table 2). There were no significant differences, however, between normal and quasi-normal spermatozoa in that regard (Table 2). All aneuploidy that we found in this study involved either 19 (n-1), or 21 (n+1), and its incidence was 01.9%. This is in agreement with a previous report indicating that hyperploidy occurs in less than 0.4% of secondary spermatocytes in BALB/c [19]. Lee et al. [20] found that the incidence of structural chromosome aberrations in human spermatozoa with deformed heads (26.1%) was almost four times higher than in those with normal heads (6.9%). Although it has been believed that there are no correlations between sperm (head) morphology, concentrations of DNA/non-DNA materials, and the sperm karyotype [4, 18, 2123], our results suggest that structurally abnormal spermatozoa are apt to have chromosome abnormalities.
According to the study by Hugenholtz and Bruce [24], various mutagenic agents can induce misshapen mouse spermatozoa. These investigators maintain that sperm shape is highly controlled by various autosomal and sex chromosomal factors and is highly heritable. The high incidence of chromosome aberrations reported here in structurally abnormal spermatozoa could be due to the action of defective genes that cause abnormalities in sperm chromosomes as well as in sperm head morphology.
The nuclei of structurally normal and abnormal spermatozoa may differ in the rate of decondensation after entry in the oocytes. According to Tateno and Kamiguchi [25], sperm chromosomes tend to break when decondensation of sperm nuclei within activated oocytes is delayed. Even though there may be no strict relationship between sperm head morphology and S-S concentration of sperm protamine [21, 23], differences in some other structural or chemical components of normal and abnormal spermatozoa may result in marked differences in the behavior of their nuclei within oocytes.
Finally, the unexpectedly high incidence of chromosomal abnormality reported here may be due, in part, to the techniques employed. Whole sperm heads or even entire spermatozoa were injected directly into oocytes. The intact acrosome and the overlying sperm plasma membrane, which never enter the ooplasm during normal fertilization [26], were injected into the ooplasm. Kimura et al. [27] showed that mouse oocytes injected with mouse spermatozoa survived and developed into normal offspring, whereas those injected with hamster or rabbit spermatozoa did not. Even though mouse oocytes were activated by hamster and rabbit spermatozoa, all of them became deformed and then degenerated (see Figs. 1 and 2 of Kimura et al. [27]). Interestingly, the oocytes survived and did not degenerate when hamster and rabbit spermatozoa were sonicated before injection. As sonication removes almost all of the acrosomal contents from sperm heads, it could be that the acrosomal contents (enzymes) in hamster and rabbit spermatozoa damaged the mouse oocytes. It is known that the acrosomal enzymes are present in the principal segment of the acrosome. As this region of the acrosome is much smaller in mouse spermatozoa than in hamster and rabbit spermatozoa [26], the survival of mouse oocytes after injection of intact mouse spermatozoa may be related to the small size of this region of the acrosome. Even though the amount of acrosomal enzymes introduced into each oocyte is very small, such exogenous enzymes may nevertheless damage the sperm nucleus. Thousands of apparently healthy human offspring have been born through the ICSI procedure [28, 29], which involves direct injection of acrosome-intact spermatozoa into oocytes. Many normal mouse offspring were also born after ICSI using acrosome-intact spermatozoa [10, 30, 31]. However, this does not imply that all the oocytes injected with acrosome-intact spermatozoa had developed normally. It is highly probable that some sperm-injected oocytes did not develop normally and were aborted before or after implantation. It is possible that the acrosome (acrosomal enzymes) introduced into an oocyte by ICSI damages the oocyte's cytoplasm and/or nucleus. Under normal conditions, the fertilizing spermatozoon discards virtually all acrosome material before it unites with an oocyte [26]. Two reports indicated that mouse and human oocytes developed better when acrosome-reacted spermatozoa were injected rather than acrosome-intact ones [31, 32]. The reason for this is unknown, but it could be that the acrosome contents (enzymes) introduced into the oocyte's cytoplasm interfere with normal embryo development. Some mouse and human oocytes may be able to tolerate exotic acrosomal enzymes, but others may not. We are now investigating whether this assumption is valid.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Correspondence: H. Kishikawa, Department of Anatomy and Reproductive Biology, University of Hawaii Medical School, 1960 East-West Road, Honolulu, HI 96822. FAX: 808 956 5474; kishi{at}uro.med.osaka-u.ac.jp ![]()
Accepted: April 29, 1999.
Received: March 5, 1999.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Yamagata, R. Suetsugu, and T. Wakayama Assessment of chromosomal integrity using a novel live-cell imaging technique in mouse embryos produced by intracytoplasmic sperm injection Hum. Reprod., July 2, 2009; (2009) dep236v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohta, Y. Sakaide, and T. Wakayama Age- and substrain-dependent sperm abnormalities in BALB/c mice and functional assessment of abnormal sperm by ICSI Hum. Reprod., April 1, 2009; 24(4): 775 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kusakabe, R. Yanagimachi, and Y. Kamiguchi Mouse and human spermatozoa can be freeze-dried without damaging their chromosomes Hum. Reprod., February 1, 2008; 23(2): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tateno and Y. Kamiguchi Evaluation of Chromosomal Risk Following Intracytoplasmic Sperm Injection in the Mouse Biol Reprod, August 1, 2007; 77(2): 336 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suganuma, R. Yanagimachi, and M. L. Meistrich Decline in fertility of mouse sperm with abnormal chromatin during epididymal passage as revealed by ICSI Hum. Reprod., November 1, 2005; 20(11): 3101 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Araki, M. Yoshizawa, and Y. Araki A novel method for chromosome analysis of human sperm using enucleated mouse oocytes Hum. Reprod., May 1, 2005; 20(5): 1244 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suganuma, C. M. Walden, T. D. Butters, F. M. Platt, R. A. Dwek, R. Yanagimachi, and A. C. van der Spoel Alkylated Imino Sugars, Reversible Male Infertility-Inducing Agents, Do Not Affect the Genetic Integrity of Male Mouse Germ Cells During Short-Term Treatment Despite Induction of Sperm Deformities Biol Reprod, April 1, 2005; 72(4): 805 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kaneko, D. G. Whittingham, and R. Yanagimachi Effect of pH Value of Freeze-Drying Solution on the Chromosome Integrity and Developmental Ability of Mouse Spermatozoa Biol Reprod, January 1, 2003; 68(1): 136 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Szczygiel, H. Kusakabe, R. Yanagimachi, and D. G. Whittingham Intracytoplasmic Sperm Injection Is More Efficient than In Vitro Fertilization for Generating Mouse Embryos from Cryopreserved Spermatozoa Biol Reprod, October 1, 2002; 67(4): 1278 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kusakabe, M. A. Szczygiel, D. G. Whittingham, and R. Yanagimachi Maintenance of genetic integrity in frozen and freeze-dried mouse spermatozoa PNAS, November 9, 2001; (2001) 241517598. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yakin and S. Kahraman Certain forms of morphological anomalies of spermatozoa may reflect chromosomal aneuploidies Hum. Reprod., August 1, 2001; 16(8): 1779 - 1780. [Full Text] [PDF] |
||||
![]() |
H. Akutsu, L. L. Tres, H. Tateno, R. Yanagimachi, and A. L. Kierszenbaum Offspring from Normal Mouse Oocytes Injected with Sperm Heads from the azh/azh Mouse Display More Severe Sperm Tail Abnormalities than the Original Mutant Biol Reprod, January 1, 2001; 64(1): 249 - 256. [Abstract] [Full Text] |
||||
![]() |
J. M. Sztein, J. S. Farley, and L. E. Mobraaten In Vitro Fertilization with Cryopreserved Inbred Mouse Sperm Biol Reprod, December 1, 2000; 63(6): 1774 - 1780. [Abstract] [Full Text] |
||||
![]() |
H. Kusakabe, M. A. Szczygiel, D. G. Whittingham, and R. Yanagimachi Inaugural Article: Maintenance of genetic integrity in frozen and freeze-dried mouse spermatozoa PNAS, November 20, 2001; 98(24): 13501 - 13506. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |